Jørgensen, E. P.
Muttuvelu, D. V.
Peto, T. http://orcid.org/0000-0001-6265-0381
Natarajan, S.
Davies, J.
Keane, P. A. http://orcid.org/0000-0002-9239-745X
Ehlers, Lars Holger http://orcid.org/0000-0001-6512-5566
Funding for this research was provided by:
Specsavers/Louis Nielsen A/S
Article History
Received: 12 December 2023
Revised: 2 May 2024
Accepted: 23 May 2024
First Online: 4 June 2024
Competing interests
: DVM is the instigator for the concept development, and implementation of the TS, and the founder of mitØje ApS. DVM further reports personal fees from Alcon in the study period. EPJ and LHE have received consultancy fees or research funding from AbbVie, AstraZeneca, Boehringer Ingelheim, Contura, Gilead, GSK, Janssen, Merck, Novartis, Novocure, Pfizer, Radiometer, and Specsavers. PK has acted as a consultant for Roche, Novartis, Boehringer-Ingleheim, Adecco, and Bitfount and is an equity owner in Big Picture Medical. He has received speaker fees from Novartis, Gyroscope, Bayer, Thea, Boehringer-Ingleheim, Apellis, Abbvie, Alimera, Roche, Genentech, Specsavers, Heidelberg Engineering, Topcon, and Santen. He has received travel support from Bayer, Topcon, and Roche. He has attended advisory boards for Boehringer-Ingleheim, RetinAI, Novartis, Apellis, Abbvie, and Roche. All authors disclose no other relationships or activities that could appear to have influenced the submitted work.
: This model-based study only contained full anonymous information, thus according to Danish guidelines, no ethical approval was required.